Deep Genomics
Deep Genomics61About
What does Deep Genomics do?
Deep Genomics is an AI-driven genetic medicines platform company that uses its Biological Foundation (BioFM) Model Platform to solve complex molecular design and target biology problems. This platform enables the discovery and development of novel genetic medicines by integrating AI model development, screening technologies, and lab-in-the-loop workflows. They aim to transform drug discovery by finding molecules and targets others would miss, accelerating the development of life-changing medicin…
What is Deep Genomics's revenue?
StartupHub estimates Deep Genomics's annual revenue at $34.9M (range $18.6M to $49.2M, 63% confidence), based on comparable companies in the sector.
What is Deep Genomics's valuation?
StartupHub estimates Deep Genomics's effective valuation at $956.0M (range $602.5M to $1.4B, 10% confidence), based on comparable companies in the sector.
How much funding has Deep Genomics raised?
Deep Genomics has raised a total of $241M in funding. The most recent round on record is Series C.
Where is Deep Genomics headquartered?
Deep Genomics is headquartered in Toronto, Canada.
When was Deep Genomics founded?
Deep Genomics was founded in 2015.
What industry does Deep Genomics operate in?
Deep Genomics operates in Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery, RNA Therapeutics, Platform.
How many employees does Deep Genomics have?
Deep Genomics has approximately 110 people on record.
No comments yet. Be the first to share your take.